Of note, one clinical trial targeting LAIR1 is listed on the website of clinicaltrials.gov (last accessed on 31 July 2025): A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms (Id. Here, LAIR1 is linked to myeloid neoplasm.